Pathogen | Antimicrobial agent | Method (unit) | Interpretive standard | |||||
---|---|---|---|---|---|---|---|---|
S | I | R | Result | Sensitivity | ||||
Streptococcus anginosus | Penicillin | MIC (ug/ml) | ≤ 0.12 | 0.25–2 | ≥ 4 | 0.064 | S | |
Linezolid | KB (mm) | ≥ 21 | NA | NA | 28 | S | ||
Levofloxacin | KB (mm) | ≥ 17 | 14–16 | ≤ 13 | 28 | S | ||
Ceftriaxone | KB (mm) | ≥ 27 | 25–26 | ≤ 24 | 30 | S | ||
Vancomycin | KB (mm) | ≥ 17 | NA | NA | 22 | S | ||
Erythromycin | KB (mm) | ≥ 21 | 16–20 | ≤ 15 | 6 | R | ||
Azithromycin | KB (mm) | ≥ 18 | 14–17 | ≤ 13 | 6 | R | ||
Clindamycin | KB (mm) | ≥ 19 | 16–18 | ≤ 15 | 6 | R | ||
Clarithromycin | KB (mm) | ≥ 21 | 17–20 | ≤ 16 | 6 | R | ||
Tetracycline | KB (mm) | ≥ 23 | 19–22 | ≤ 18 | 30 | S | ||
Staphylococcus hominis | Penicillin | MIC (ug/ml) | ≤ 0.12 | NA | ≥ 0.25 | ≥ 0.50 | R | |
Vancomycin | MIC (ug/ml) | ≤ 4 | 8–16 | ≥ 32 | 1.0 | S | ||
Gentamicin | MIC (ug/ml) | ≤ 4 | 8 | ≥ 16 | 1.0 | S | ||
Clindamycin | MIC (ug/ml) | ≤ 0.5 | 1–2 | ≥ 4 | ≥ 8.0 | R | ||
Tetracycline | MIC (ug/ml) | ≤ 4 | 8 | ≥ 16 | ≥ 16.0 | R | ||
Ciprofloxacin | MIC (ug/ml) | ≤ 1 | 2 | ≥ 4 | 1.0 | S | ||
Levofloxacin | MIC (ug/ml) | ≤ 1 | 2 | ≥ 4 | 0.5 | S | ||
Moxifloxacin | MIC (ug/ml) | ≤ 0.5 | 1 | ≥ 2 | ≤ 0.25 | S | ||
Smz-tmp | MIC (ug/ml) | ≤ 2/38 | NA | ≥ 4/76 | 80.0 | R | ||
Rifampicin | MIC (ug/ml) | ≤ 1 | 2 | ≥ 4 | ≤ 0.5 | S | ||
Quinupristin/dalfopristin | MIC (ug/ml) | ≤ 1 | 2 | ≥ 4 | 0.5 | S | ||
Linezolid | MIC (ug/ml) | ≤ 4 | NA | ≥ 8 | 2.0 | S | ||
Erythromycin | MIC (ug/ml) | ≤ 0.5 | 1–4 | ≥ 8 | ≥ 8.0 | R | ||
Oxacillin | MIC (ug/ml) | ≤ 0.25 | NA | ≥ 0.5 | ≥ 4.0 | R | ||
Methicillin resistance | Positive | |||||||
Pseudomonas aeruginosa | Piperacillin/tazobactam | MIC (ug/ml) | ≤ 16/4 | 32/4–64/4 | ≥ 128/4 | 16.0 | S | |
Ceftazidime | MIC (ug/ml) | ≤ 8 | 16 | ≥ 32 | 32.0 | R | ||
Imipenenm | MIC (ug/ml) | ≤ 2 | 4 | ≥ 8 | ≥ 16.0 | R | ||
Meropenem | MIC (ug/ml) | ≤ 2 | 4 | ≥ 8 | ≤ 0.25 | S | ||
Amikacin | MIC (ug/ml) | ≤ 16 | 32 | ≥ 64 | ≥ 64.0 | R | ||
Ciprofloxacin | MIC (ug/ml) | ≤ 0.5 | 1 | ≥ 2 | 0.5 | S | ||
Levofloxacin | MIC (ug/ml) | ≤ 1 | 2 | ≥ 4 | 1.0 | S | ||
Cefoperazone/sulbactam | MIC (ug/ml) | ≤ 16 | 32 | ≥ 64 | 32.0 | I | ||
Cefepime | MIC (ug/ml) | ≤ 8 | 16 | ≥ 32 | 16.0 | I | ||
Tobramycin | MIC (ug/ml) | ≤ 4 | 8 | ≥ 16 | 2.0 | S | ||
Polymyxin | MIC (ug/ml) | ≤ 2 | NA | ≥ 4 | 2.0 | S | ||
Gentamicin | KB (mm) | ≥ 15 | 13–14 | ≤ 12 | 17 | S |